drugset / Trial / NCT00195234

Study Evaluating Vaccine in Adults With HIV

NCT00195234

Phase 1 Completed 60 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to learn whether the study vaccine and adjuvants (drugs that are used to help improve immune responses) have an acceptable safety profile in treating individuals with HIV. A second purpose of this study is to understand how the immune system responds to the study vaccine and adjuvants.

Timeline

Start
2004-12
Primary completion
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject HIV CTL MEP Vaccine 1000 ug